MGMT and glioblastoma: Likewise, concurrent anti-PD-1 and radiotherapy did not improve the outcomes of newly diagnosed patients with GBM with unmethylated MGMT promoter, where nearly 30% of patients were receiving corticosteroids at baseline6.